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The  human  Ia  antigens,  products  of the  genes  of the  major  histocompatibility 
complex,  were  first  recognized  primarily  on  the  B  lymphocytes  by  alloantisera 
obtained from pregnant or transplant subjects (1, 2). Heteroantisera were subsequently 
prepared  by  immunizing  rabbits  with  highly  purified  antigens  from  solubilized 
membrane  fractions of B-lymphoblastoid cell-line cells (3,  4).  With the use of these 
antisera, it became apparent that a  very small but definite percentage of peripheral 
blood T  lymphocytes express such antigens (5). During the study, a  few patients with 
elevated  levels  were  also  encountered.  In  addition,  considerable  elevations  of the 
percentages of Ia  + T  cells have been found after stimulation with mitogens or during 
mixed leukocyte culture (MLC) 1 reaction (6-8).  Patients with infectious mononucle- 
osis (9) and graft-vs.-host reaction (10) also have been reported to show elevated levels 
of Ia-positive T  cells. 
In this study a  broader examination of the Ia marker on T  lymphocytes of patients 
with various diseases was made, employing both the allo- and heteroantisera as well 
as  mouse  monoclonal  antibodies  to  Ia  determinants.  Special  efforts  were  directed 
towards gaining an understanding of the significance of the elevations observed. 
Materials and Methods 
Patient  Selection.  Patients  were  selected  from  the  clinics  and  wards  of the  Rockefeller 
Hospital, Hospital for  Special Surgery, New  York  Hospital, and  Memorial Hospital  (New 
York). 
Isolation of T Lymphocytes.  Peripheral blood mononuclear cells were separated from heparin- 
ized blood samples by Ficoll (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.)  -Hypaque 
(Winthrop Laboratories, New York) gradients. T  lymphocytes were isolated by rosetting these 
mononuclear cells with neuraminidase-treated sheep erythrocytes (RBC). The lymphocytes in 
these preparations usually consisted of 98% sheep RBC rosette-forming cells (RFC) and <2% 
surface Igobearing cells. They were designated as T  preparations. Details of these procedures 
have been reported previously (5). 
Surface Staining  with Immunofluorescent Reagents.  The rabbit anti-Ia antiserum used was the 
same and previously characterized as being highly specific for the broad group of Ia antigens 
(4). It was conjugated with rhodamine and absorbed with Ia-negative T-lymphoblastoid cell- 
line  cells.  Direct  immunofluorescent  staining  was  carried  out  using  F(ab')  2  fragments  as 
described  previously  (5).  As  noted  in  the  previous  study,  the  Ia  +  T  lymphocytes  in  the 
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Foundation grant RF 70095. 
1 Abbreviations used in this paper: MLC, mixed leukocyte culture;  PBS, phosphate-buffered  saline; PPD, 
purified protein derivative(s); RBC, erythrocyte(s); RFC, rosette-forming cells. 
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preparations  could be distinguished  from the small numbers  of contaminating  monocytes by 
the  weaker  intensity  of  the  fluorescence.  In  addition,  double  marker  analyses,  as  shown 
previously (5),  demonstrated  that  these cells formed rosettes with SRBC. The number of this 
type of positive cells was expressed as a  percentage of the T-lymphocyte preparations. 
To assess the allospecificities, the cells were first incubated with rabbit Cohn fraction II heat 
aggregated  at  10  mg/ml in  phosphate-buffered  saline  (PBS)  at  63°C  for  10  min,  then  with 
type-specific alloantisera, and, lastly, after three washings with PBS-1% bovine serum albumin, 
with rhodamine-conjugated  goat antibodies directed against the Fc portions of human  immu- 
noglobulins (1). 
To obtain  Ia specific monoclonal antibodies,  spleen cells from mice immunized with  a  B- 
lymphoblastoid  cell  line  were  fused  with  a  mouse  myeloma  cell  line  (11).  The  antibodies 
secreted by one of these continuous cell lines were shown to react with the typical 28,000- and 
37,000-dalton  Ia components and to show a  general specificity similar to the heteroantiserum. 
Lymphocytes were stained  by reacting first with these antibodies at room temperature  for 30 
rain  and  subsequently  with  a  preparation  of  rhodamine-conjugated  sheep  anti-mouse  Ig 
antibodies. 
Indirect Rosette Assay.  Isolated sheep  anti-rabbit  Ig antibodies  (12)  were coupled to bovine 
RBC by the chromium chloride method (13), resuspended  in RPMI  (Grand Island Biological 
Co., Grand Island,  N. Y.)  -10% fetal calf sera and kept at 4°C. The rosette assay was carried 
out  in microtitre plates  (Cooke Engineering Co., Alexandria, Va.).  To each well of the plate 
6  was aliquoted 20 p.l of lymphocytes at  10 ×  10/ml in RPMI and 20/~1 of optimum dilution of 
the  rabbit  anti-Ia  antiserum.  After 30  min  of room  temperature  incubation,  the  cells were 
washed five times with PBS. After the last wash, 40/xl of a 2% suspension of the sensitized RBC 
were added to each well. The plates were centrifuged at 300 g for 5 min and kept at 4°C for 60 
min. 10 ~tl of 1.0% toluidine blue were pipetted to each well and the ceils vigorously resuspended 
by Pasteur pipettes. The percentages of RFC were determined by microscopic examination of 
200  cells.  Control samples  were carried out  in parallel  in  which  a  normal  rabbit  serum  was 
substituted  for the rabbit  anti-Ia antiserum. 
Autoradiography.  Cytocentrifuge slide preparations of lymphocytes that had been labeled by 
a brief incubation with tritiated thymidine were coated with NTB2 emulsion (Eastman Kodak 
Co., Rochester, N. Y.) and stored in the dark for 2 d. After developing and fixing, the cells were 
stained with Giemsa stains.  Positively labeled cells showed >5 grains/cell. 
In  Vivo Immunization with  Tetanus Toxoid and Purified Protein Derivatives.  Five normal subjects 
were given 0.5 ml of tetanus toxoid (The Upjohn Co., Kalamazoo, Mich.) subcutaneously.  One 
other subject received an  intracutaneous  injection of 0.1  ml of purified protein  derivatives of 
tubercle bacilli (Parke,  Davis & Co., Detroit, Mich.).  10-ml samples of peripheral  blood were 
collected  before  the  immunization  and  at  various  days  afterwards.  All  venipunctures  were 
carried out between 8:00 and 9:00 a.m. 
In  Vitro Lymphocyte Culture.  T  lymphocytes obtained  as  described  above were mixed with 
irradiated autologous monocytes at a  ratio of 9:1. The latter were isolated by centrifugation of 
peripheral  blood mononuclear cells on bovine serum albumin  solution of density  1.386 g/ml. 
These cells were cultured  at  1.5  ×  106 eells/ml in  RPMI-10%  AB sera  with  0.04  mg/ml of 
tetanus  toxoid  in  a  37°C  5%  CO2  incubator.  Aliquots  were  harvested  every  day  for  the 
immunofluorescent study. Because the monocytes adhered to the plastic surfaces of the culture 
plates (Linbro 76-033-05, Linbro Chemical Co., Hamden, Conn.), they constituted <2% of the 
cells in the harvested samples, as identified by cytocentrifuge preparations. 
Results 
Levels in  Various Diseases as Compared with Normats 
NORMAL SUBJECTS.  The percentages ofIa + T  cells in the peripheral blood lympho- 
cyte preparations  of 12 normal  male and  12 normal  female volunteers ranged  from 0 
to  4.8%  by  fluorescent  analysis  (Fig.  1).  They  were -->3.0%  in  10  subjects  and  --<1.0% 
in  6.  The  upper  limit  of normal  was  regarded  as  6.0%,  which  was  the  sum  of the 
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FIc.  1.  Percentages of Ia  + cells  in the T  preparations of normal individuals and patients with 
various conditions. RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; IBD, inflamma- 
tory bowel diseases;  MS, multiple sclerosis; HL, hyperlipidemia. 
was 2.6%. These results were obtained by using F(ab')z fragments of the rabbit anti- 
Ia antibodies in a  direct fluorescence assay. 
Somewhat  higher values were obtained  for the same anti-Ia rabbit antiserum  by 
the sensitive rosette assay employing bovine RBC  coated with isolated antibodies to 
rabbit Ig (Table I). For 10 normal individuals a  range of 7.3-15.0% was obtained. As 
a  control, normal rabbit serum was used in place of the anti-Ia antiserum, which was 
essential  because  this  was  an  indirect  assay  and  T  cells  with  Fc  receptors  could 
interfere.  In  most  instances  low  background  levels with  normal  rabbit  serum  were 
obtained, but significant levels were sometimes observed. 
RHEUMATOID ARTHRITIS.  After encountering a  high percentage of Ia  + T  cells in an 
initial patient with  rheumatoid  arthritis, a  large population of rheumatoid  arthritis 
patients was studied by fluorescence. In 21  of the 23 patients, the percentage of these 
cells exceeded the upper limit of the normal values (Fig.  1).  In  14 of the 23 patients, 
the  values  exceeded  10%.  As  in  those  samples  obtained  from  normal  subjects, 
approximately one-half to three-fourths of the cells observed here and subsequently in 
patients  with  other  diseases  were  stained  rather  faintly.  9  of the  23  patients  were 
regarded by their physicians as having clinically active disease; the majority were not 
receiving corticosteroids or immunosuppressive therapy. The two patients with normal 
percentages of Ia  + T  cells were relatively inactive cases. 
The elevated levels in  the rheumatoid arthritis patients were also apparent  using 
the  rosette  assay. Table  I  shows  the  results for  nine  patients  as compared with  the 
values obtained by fluorescence. 
Fluorescence studies were also carried out with antibodies from a  hybridoma that 
had  been  demonstrated  to show  Ia specificity very similar to  the rabbit  antiserum. 
The elevated levels in rheumatoid arthritis were clearly apparent with the hybridoma 
antibodies, and very parallel results to those illustrated for the rabbit antiserum were 
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TABLE  I 
Percentages of Positive T Cells from Normal Individuals and Patients with 
Rheumatoid Arthritis Determined by Fluorescence  and by Rosette Assays Using 
the Heteroantiserum 
Positively  stained  RFC 
ceils 
Normal subjects 
1  4.8  15.0  (2.0)* 
2  3.0  11.7 (0.5) 
3  2.4  12.3 (0.9) 
4  2.4  8.0 (0.0) 
5  2.0  12.4 (5.0) 
6  2.0  11.3 (0.0) 
7  2.0  7.3 (1.0) 
8  1.2  7.7 (1.0) 
9  0.8  13.7 (1.4) 
10  0.5  9.0 (3.0) 
Rheumatoid arthritis 
1  36.5  32.8 (0.0) 
2  32.0  39.7 (2.5) 
3  28.0  40.0 (3.0) 
4  17.0  30.9 (2.0) 
5  16.5  23.0 (0.0) 
6  9.9  28.4 (2.4) 
7  9.0  12.0 (0.0) 
8  7.0  25.1 (ND)~z 
9  3.2  7.6 (ND) 
* Background levels  with normal rabbit serum. 
:~ Not done. 
SYSTEMIC LUPUS ERYTHEMATOSUS.  The  Ia  +  T  cells  of  16  patients with  systemic 
lupus erythematosus ranged from  1.4  to  21.2%  by fluorescence analysis. In nine of 
them  the  percentages were  above  the  normal values.  In seven of them  the  values 
exceeded  10%.  Most of the patients were receiving steroids when examined; the role 
of such therapy was not examined here. 
MISCELLANEOUS DISEASES WITH ELEVATED LEVELS.  Three patients with active bac- 
terial  infections had  elevated  levels  of Ia  +  T  cells  by  immunofluorescence. They 
suffered  from  staphylococcal  aureus  osteomyelitis,  pneumococcal pneumonia, and 
acute cholecystitis. The percentages of Ia  + T  cells by fluorescence were 25.4, 13.9, and 
18,  respectively. One patient with idiopathic thrombocytopenic purpura had  25.7% 
Ia  + T  cells.  Four of six patients with  inflammatory bowel diseases also had  mildly 
elevated percentages ranging from 6.3 to  12.3. 
DISEASES WITHOUT ELEVATED LEVELS.  OUt of 10 patients with multiple sclerosis, 8 
with hyperlipidemia, 3 with degenerative  joint disease, and 10 with nonlymphomatous 
tumors of various organs not on chemotherapy, elevated levels were detected in only 
one patient with hyperlipidemia and one with salivary gland adenocarcinoma. The 
values in these two subjects were 6.3 and 9.8% by immunofluorescence, respectively. 
Patients with the  following disorders had normal percentages of Ia  + T  cells:  recent 
operation for abdominal aneurysm, chronic obstructive lung disease, acute thrombo- 
phlebitis of lower extremity, recent myocardial infarction, chronic rheumatic disease, YU,  WINCHESTER,  FU, GIBOFSKY,  KO, AN[) KUNKEL 
TABLE II 
Percentages of T Cells Stained by the Rabbit Anti-Ia  Antiserum and by the 
Monoclonal Antibody 
Monoclonal  Rabbit anti-la  antibody 
Normal subjects 
1  4.8  5.0 
2  3.0  2.5 
3  2.5  1.5 
4  1.0  0.0 
5  0.5  1.0 
Rheumatoid arthritis 
1  11.0  10.0 
2  22.5  17.5 
3  12.5  10.0 
4  15.2  16.3 
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pulmonary  embolism,  alcoholic  gastritis  with  bleeding,  asthma,  diabetes  mellitus, 
alcoholic gastritis with megaloblastic anemia, cerebrovascular accident, and subacute 
sclerosing penencephalitis. 
SEROTYPES OF B AND T CELLS.  The allospecificity of the Ia antigens on  the B  cells 
of three  rheumatoid  arthritis patients was  determined  by the  microcytoxicity tech- 
nique  (14).  Their  T  lymphocytes  were  stained  with  alloantisera of predetermined 
specificity as described. Considerable background staining was obtained with normal 
serum  and  all  the  alloantisera, probably  a  reflection  of the  Fc  receptors on  the T 
lymphocytes. However, in each  individual, the highest  values were obtained by the 
antisera that  also reacted with  the individual's B  lymphocytes. Similar studies were 
carried out  in  normal  individuals. The  percentages  of positively stained  cells were 
much less (Table III). 
Immunization Effects 
In  view  of the  known  in  vitro  effects  of  mitogens  and  MLC  reactions  on  the 
generation of Ia  ÷ T  cells, the in vivo effects of immunization were studied that might 
be relevant to the increased numbers of Ia  + T  cells in disease. Normal subjects who 
had  received  tetanus  immunization  5-10  yr  previously were  given  an  injection  of 
tetanus toxoid. Elevated levels of Ia  + T  cells were produced and this occurred within 
2  d  after  the  injection.  Fig.  2  illustrates the  results  in  one  individual  utilizing the 
rabbit  antiserum.  Also shown  is the curve  for Ia  +  T  cells after  in  vitro stimulation 
with tetanus toxoid for the same individual. The markedly slower onset of positive T 
cells in the in vitro response is apparent.  Similar results were obtained in three other 
individuals. The character of the positive cells also differed very significantly in the in 
vitro and the in vivo response. The cells in the latter cases were small T  cells whereas 
in the in vitro case large blastoid cells were involved. 
Similar results were obtained after purified protein derivative (PPD) administration 
(Fig.  3).  Again  a  rapid  rise  was  observed  after  in  vivo  stimulation,  and  the  cells 
involved were  very similar to those observed for the tetanus system. Also plotted in 
this  case  is  the  curve  utilizing  the  anti-DRw3  alloantiserum.  This  appropriate 
specificity, known  from  B-cell typing on  this individual, follows the curve obtained 96  PERIPHERAL  BLOOD Ia-POSITIVE  T  CELLS 
TABLE III 
Percentages of T Cells from Rheumatoid Arthritis Patients and Normal Subjects Stained by Anti-DR 
Alloantisera in Indirect Fluorescence Assay Compared with Heteroantiserum Staining by Direct 
Fluorescence 
B-Cell types 
Rheumatoid arthritis  Normal 
C.R.  J.V.  C.S.  R.W.  J.P. 
(DRw4)*  (DRw4)*  (DRw3,4)*  (DRw3,4)*  (DRw2,4)* 
Rabbit anti-Ia  23  23  19.5  1.6  0.6 
Normal human serum  5  6  9  2.5  0.8 
Serum 191 (anti-DRw4)  17  19  29  0.8  1.3 
Serum 932 (anti-DRw3)  5  5  27  3.4  1.3 
Serum 2359 (anti-DRw7)  8  2  6  1.5  1.2 
* Phenotype as determined by microcytotoxicity  assay on purified B cells. 
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F]c.  2.  Effect of in vivo immunization and in vitro culture with tetanus toxoid on the percentages 
of Ia  + T cells. 
with the rabbit Ia antiserum. The inappropriate specificity control showed negative 
results. 
Miscellaneous Studies 
Cytocentrifuge preparations of the  peripheral  blood  T  lymphocytes were  made 
from three rheumatoid arthritis patients whose Ia  + cells were 20.0,  20.8, and 5.9%. 
Less  than  0.2%  of  the  cells  appeared  morphologically  as  lymphoblasts.  Similar 
preparations were also examined for the T  ceils of one of the subjects who received 
the  PPD.  The percentages of lymphoblasts remained <2%  at  a  time when the  Ia  + 
cells were 25%. 
T-lymphocyte preparations from  four rheumatoid arthritis patients whose Ia  + T 
cells were 5.9,  14.4,  17.8, and 20.8% were examined by autoradiography. Less than 
0.1% of the cells from each case incorporated radioactive thymidine. 
Studies  were  also  carried  out  in  normal  and  rheumatoid  arthritis  patients  on 
whether the Ia  + cells were in the Tv or non-T  v fraction of T  cells. Isolation of the T v 
fraction showed  definite enrichment of Ia  +  cells, which,  in some instances, were  as 
high  as  50%  of the  Tv cells.  However,  in  both  the  normals  and  the  rheumatoid 
arthritis patients, significant numbers of Ia  + cells were found in the non-T  v fraction, 
which was virtually free of contaminating  Ty cells. In addition, certain of the patients 
showed levels of Ia positive T  cells that were considerably higher than the Ty levels. 
These relationships were clearly complex and will be published in detail separately. YU, WINCHESTER, FU,  GIBOFSKY,  KO, AND  KUNKEL  97 
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F~c.  S.  Effect of in vivo skin test with PPD on the percentages of T  cel|s stained by rabbit anti-Ia 
antiserum and anti-DRw3 alloantiserum. 
Discussion 
It  is  apparent  from  our  study that  increased  numbers  of Ia  + T  cells  frequently 
appear  in  the  circulation  in  disease.  This  was  especially  striking  in  patients  with 
rheumatoid arthritis  and systemic lupus erythematosus, but also evident in patients 
with infections and a number of miscellaneous conditions. Various metabolic disorders 
showed close  to  normal  levels.  It  is  of special  interest  that  patients  with  multiple 
sclerosis  also showed normal levels, in striking contrast to patients with systemic lupus 
erythematosus and rheumatoid arthritis,  diseases with multiple  autoimmune mani- 
festations. Although well over 100 individuals were examined in our survey, the study 
remains incomplete and other specific disorders require investigation. A limited earlier 
survey from our laboratory did  not reveal elevated  levels  in  patients with  immune 
deficiency disease;  however, one patient with elevated levels  has been reported  (15). 
In addition,  patients  with  infectious  mononucleosis and  graft-vs.-host disease  have 
been found to have high levels  (9,  10). 
In a  previous study (5),  it was demonstrated that a  small but definite number of 
Ia  + T  cells is  found in normal individuals.  This was confirmed in this study, and a 
mean of 2.6%  was found, a  value very similar to that  reported recently by another 
group of investigators (16).  Our study demonstrated that blast cells  were not signifi- 
cantly involved and the Ia  + normal and disease T cells were very similar and consisted 
primarily of small lymphocytes. They clearly differed from the in vitro stimulated Ia  + 
T  cells,  which are almost entirely large blastoid cells.  The studies  in diseases where 
these cells reached very substantial levels add significance to the cells found in normal 
individuals despite their low concentration. 
To corroborate that  the  increases in  the positively stained  cells  were indeed  Ia  +, 
two  other  types  of  antisera  were  used  in  addition  to  the  highly  specific  rabbit 
antiserum  primarily  employed and  previously described  (4,  5),  a  broadly  reactive 
anti-Ia hybridoma and  alloantisera  of known  DR  specificity.  The  results  obtained 
with  the  monoclonal antibodies  were  very similar  to those obtained  by the  rabbit 
anti-Ia antiserum. The results with the alloantisera indicated that the allospecificities 
of the  Ia  +  T  cells  were  the  same  as  those  of the  B  lymphocytes from  the  same 
individual. Besides using the immunofluorescent reagents, Ia  + cells were also detected 
by the  indirect  rosette  technique  (17).  This was carried  out  by first  sensitizing the 
lymphocytes with rabbit anti-Ia antiserum and then rosetting them with bovine RBCI 
to which were coupled isolated sheep  anti-rabbit-Ig antibodies.  The percentages of 98  PERIPttERAL  BLOOD  Ia-POSITIVE T  CELLS 
RFC  were  somewhat  higher than  the  immunofluorescent  positive cells in  line with 
the known greater sensitivity of this rosette method. 
The  chief clue regarding  the  significance of the  Ia  ÷ T  cells described above was 
gained from a  study of the effects of immunization of normal  individuals. Adminis- 
tration of tetanus toxoid or PPD in sensitized subjects who developed reactions at the 
site of injection resulted in a  marked increase in the number of circulating Ia  ÷ T  cells. 
An increase from an initial level of 1.6 to 28% was observed in one instance. These Ia  + 
T  cells closely resembled those observed in the normal and diseased individuals, and, 
again, blastoid cells were  not  significantly involved. It is of special interest  that  the 
positive T  cells appeared  quite soon  after  immunization,  usually within  48  h.  This 
stood  in  marked  contrast  to  the  late  appearance  of  Ia  +  T  blasts  after  in  vitro 
stimulation with the same antigens and the cells of the same individuals. 
The  exact  origin  and  significance of these  Ia  +  T  cells remains  to  be  elucidated. 
Their enrichment  in the Tv fraction of T  cells indicates that  they are present in this 
fraction. However, they clearly also were present in the non-Tv fraction. Thus it would 
appear that more than one T-cell fraction is involved, although  it is not as yet clear 
how selective a  fraction  the Ty really is. The similarity between  the situation in the 
normal and the elevations in disease suggests that these cells might be recruited into 
the  circulation  after  antigen  injection  in  sensitized  individuals  or  during  disease 
processes involving antigenic stimulation. Another possibility is that they result from 
some  type  of  stimulation  by  antigens.  Numerous  workers  have  described  small 
numbers of blastoid cells and DNA-synthesizing cells in the circulation of individuals 
with some of the diseases described above (18-22). Our studies indicate that such cells 
do  not  account  for  the  Ia  +  T  cells observed;  however,  the  Ia  antigens  might  have 
developed from minor degrees of T-cell stimulation without overt blastogenesis or cell 
division, although  such  cells were  not  observed during  in  vitro stimulation.  It  also 
remains  a  possibility  that  the  |a  antigens  are  derived  from  other  cells  such  as 
stimulated B  cells or macrophages  and  are simply adsorbed to the surface of the T 
cells. Evidence against  this was  obtained  from  elution  studies where  these antigens 
failed to be removed under conditions known  to cause elution of some adsorbed Ia 
antigens.  In addition, serial determinations in normal individuals and  patients with 
rheumatoid  arthritis showed  a  relative constancy  of the  positive T-cell  levels.  Irre- 
spective of the  precise mechanism  involved in  the  development  of these cells, their 
wide occurrence in patients with rheumatoid arthritis, a  disease of unknown etiology, 
appears of special interest and may furnish new guides for further work in this disease. 
Summary 
The  Ia  antigens,  usually expressed  primarily on  B  lymphocytes,  are  found  on  a 
small percentage of normal  peripheral blood T  cells  (average  2.6%  by  fluorescence 
and  10.8% by rosette assay). Elevated levels up to 40% by both assays were observed 
in a  high proportion of patients with rheumatoid arthritis. Increases also were found 
in  patients  with  systemic lupus  erythematosus  and  various types of infections.  The 
increases were evident with a specific heteroantiserum, a hybridoma reagent, and DR 
specific alloantisera. Normal levels were present in multiple sclerosis and an assortment 
of  metabolic  and  other  disorders.  A  rise  in  similarly positive  T  cells  occurred  in 
normal  individuals after  immunization  with  tetanus  toxoid or  PPD.  The  cells pri- 
marily  involved  in  all  of  these  instances  were  small  lymphocytes,  which  stained YU,  WINCHESTER,  FU, GIBOFSKY,  KO, AND KUNKEL  99 
relatively weakly with the fluorescent reagents and were readily distinguishable from 
T-cell blasts. They were  found  to be enriched  in isolated Tv fractions but  were also 
found in other T  cells. The accumulated evidence indicated that these cells represent 
an expansion of one or more subsets ofT  cells found in normal individuals, and that 
their level in the peripheral blood may serve as an index of immunological stimulation. 
Received  for publication 18 September 1979. 
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